Meningococcemia

Explore clinical trials studying Meningococcemia. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Meningococcemia trial results

Completed

Immunology and Safety of Menactra® in Children in Saudi Arabia

NCT00539032

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: AlKhaleej, Al-Qassim Region, Saudi Arabia

AlRabwa, Al-Qassim Region, Saudi Arabia

S. Buraida, Al-Qassim Region, Saudi Arabia

Safra-Al Midhnab, Al-Qassim Region, Saudi Arabia

View Trial Details

Completed

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

NCT00771849

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: London, United Kingdom

London, United Kingdom

View Trial Details

Completed

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

NCT00700713

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: Marietta, Georgia, United States

Woodstock, Georgia, United States

Bardstown, Kentucky, United States

Annapolis, Maryland, United States

View all 13 locations

View Trial Details

Completed

Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

NCT00777790

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: Atlanta, Georgia, United States

Marietta, Georgia, United States

Woburn, Massachusetts, United States

Albany, New York, United States

View Trial Details

Completed

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

NCT00772070

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +8 more
Locations: Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

Woburn, Massachusetts, United States

Bridgeton, Missouri, United States

View Trial Details

Completed

Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine

NCT00777257

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations: Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

Boulder, Colorado, United States

Marietta, Georgia, United States

View all 20 locations

View Trial Details

Completed

Correlation Between Cytokines and the Severity of Meningococcal Disease

NCT01133834

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations: University of São Paulo General Hospital - LIM-12 and LIM-56 São Paulo, Brazil

View Trial Details

Meningococcemia

Meningococcemia trial results

Immunology and Safety of Menactra® in Children in Saudi Arabia

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine

Correlation Between Cytokines and the Severity of Meningococcal Disease

Related conditions